Notably, these observations were based on the activation of TGFB1 expression, whereas our prognostic model suggested that the TGFB2 mRNA isomer drove a positive prognostic impact in breast cancers, indicating the need for a careful and nuanced examination of the TGFB ligand isoforms in tumor progression. Here, TGFB2 is linked to neoplasm.